Lu S - Search Results

1

ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer.

Wong TL, Loh JJ, Lu S, Yan HHN, Siu HC, Xi R, Chan D, Kam MJF, Zhou L, Tong M, Copland JA, Chen L, Yun JP, Leung SY, Ma S. Wong TL, et al. Among authors: lu s. Nat Commun. 2023 May 19;14(1):2861. doi: 10.1038/s41467-023-38581-8. Nat Commun. 2023. PMID: 37208334 Free PMC article.

2

Decrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis.

Luo R, Zhang M, Liu L, Lu S, Zhang CZ, Yun J. Luo R, et al. Among authors: lu s. PLoS One. 2013 Aug 1;8(8):e70511. doi: 10.1371/journal.pone.0070511. Print 2013. PLoS One. 2013. PMID: 23936443 Free PMC article.

3

miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.

Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou X, Zhang ZJ, Peng YH, Yang YZ, Yun JP. Li LZ, et al. Carcinogenesis. 2014 Feb;35(2):469-78. doi: 10.1093/carcin/bgt330. Epub 2013 Oct 1. Carcinogenesis. 2014. PMID: 24085799

4

FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2.

Liu LL, Lu SX, Li M, Li LZ, Fu J, Hu W, Yang YZ, Luo RZ, Zhang CZ, Yun JP. Liu LL, et al. Oncotarget. 2014 Jul 15;5(13):5113-24. doi: 10.18632/oncotarget.2089. Oncotarget. 2014. PMID: 24970808 Free PMC article.

5

Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.

Hu W, Lu SX, Li M, Zhang C, Liu LL, Fu J, Jin JT, Luo RZ, Zhang CZ, Yun JP. Hu W, et al. Oncotarget. 2015 Mar 30;6(9):6570-83. doi: 10.18632/oncotarget.3262. Oncotarget. 2015. PMID: 25788265 Free PMC article.

6

Decrease of Bcl-xL/Bcl-2-associated death promoter in hepatocellular carcinoma indicates poor prognosis.

Hu W, Fu J, Lu SX, Liu LL, Luo RZ, Yun JP, Zhang CZ. Hu W, et al. Am J Cancer Res. 2015 Apr 15;5(5):1805-13. eCollection 2015. Am J Cancer Res. 2015. PMID: 26175948 Free PMC article.

7

A scoring system based on artificial neural network for predicting 10-year survival in stage II A colon cancer patients after radical surgery.

Peng JH, Fang YJ, Li CX, Ou QJ, Jiang W, Lu SX, Lu ZH, Li PX, Yun JP, Zhang RX, Pan ZZ, Wan de S. Peng JH, et al. Among authors: lu zh, lu sx. Oncotarget. 2016 Apr 19;7(16):22939-47. doi: 10.18632/oncotarget.8217. Oncotarget. 2016. PMID: 27008710 Free PMC article.

8

Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.

Lu SX, Zhang CZ, Luo RZ, Wang CH, Liu LL, Fu J, Zhang L, Wang H, Xie D, Yun JP. Lu SX, et al. Cancer Lett. 2017 Aug 28;402:71-80. doi: 10.1016/j.canlet.2017.05.018. Epub 2017 Jun 1. Cancer Lett. 2017. PMID: 28577975

9

HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis.

Chen SL, Liu LL, Lu SX, Luo RZ, Wang CH, Wang H, Cai SH, Yang X, Xie D, Zhang CZ, Yun JP. Chen SL, et al. Mol Oncol. 2017 Sep;11(9):1225-1240. doi: 10.1002/1878-0261.12090. Epub 2017 Jul 11. Mol Oncol. 2017. PMID: 28580773 Free PMC article.

10

Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinoma.

Cai SH, Lu SX, Liu LL, Zhang CZ, Yun JP. Cai SH, et al. Therap Adv Gastroenterol. 2017 Oct;10(10):761-771. doi: 10.1177/1756283X17725998. Epub 2017 Aug 25. Therap Adv Gastroenterol. 2017. PMID: 29051787 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,073 results

Search Page

Filters